A very recent study showed that auto-reactive human primary B cells from RA patients can efficiently acquire the auto-antigen, aggrecan, in a BCR- and adhesion-dependent manner (Ciechomska et al., 2014). The gene discussed is BCR; the disease is rheumatoid arthritis.